EZH2, belonging to the polycomb-group (PcG) family, has been reported to be greatly overexpressed in lung specimens, and upregulation of EZH2 predicts dismal survival of NSCLC (10). This evidence concerns the gene EZH2 and non-small cell lung carcinoma.